Nilisha Fernando

Nilisha Fernando is a Medical Writer at Envision Pharma Group since October 2022, focusing on clinical publications and medical communications. Previously, Nilisha served as an Associate Medical Writer at the National Institutes of Health, where research involved immune system dysregulation in neurodegenerative diseases during a Postdoctoral Fellowship. Additional experience includes eight years of research on retinal degeneration at The Australian National University, a Technical Officer role with Beta Therapeutics, and teaching as a Lab Demonstrator. Early career roles include positions as a Retail Assistant and a Science Communicator at CSIRO. Nilisha holds a PhD in Vision Science/Physiological Optics and a Bachelor of Medical Science with Honours from The Australian National University.